The Valley Desk

NCT03748186 · Interventional trial

Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers

Overall registry status Completed

Phase 1

Conditions Endometrial Cancer, Endometrioid Adenocarcinoma, Fallopian Tube Cancer, Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer, Primary Peritoneal Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov